▶ 調査レポート

腫瘍溶解性ウイルスの世界市場レポート2020

• 英文タイトル:Global Oncolytic Virus Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。腫瘍溶解性ウイルスの世界市場レポート2020 / Global Oncolytic Virus Sales Market Report 2020 / MRC2102QY10017資料のイメージです。• レポートコード:MRC2102QY10017
• 出版社/出版日:QYResearch / 2021年1月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、139ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥600,000 (USD4,000)▷ お問い合わせ
  Multi User¥900,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,200,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界の腫瘍溶解性ウイルス市場について種類別(Imlygic、Oncorine、その他)、用途別(黒色腫、その他のがん)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・腫瘍溶解性ウイルス市場の概要
・世界の主要地域別腫瘍溶解性ウイルス市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の腫瘍溶解性ウイルス市場規模2015-2026:種類別(Imlygic、Oncorine、その他)
・世界の腫瘍溶解性ウイルス市場規模2015-2026:用途別(黒色腫、その他のがん)
・腫瘍溶解性ウイルスの米国市場規模2015-2020
・腫瘍溶解性ウイルスのヨーロッパ市場規模2015-2020
・腫瘍溶解性ウイルスの中国市場規模2015-2020
・腫瘍溶解性ウイルスの日本市場規模2015-2020
・腫瘍溶解性ウイルスの東南アジア市場規模2015-2020
・腫瘍溶解性ウイルスのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・腫瘍溶解性ウイルスの製造コスト分析
・販売チャネル、流通業者、顧客
・腫瘍溶解性ウイルスの市場動向・機会・課題
・調査の結論

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.

Market Analysis and Insights: Global Oncolytic Virus Market
The global Oncolytic Virus market size is projected to reach US$ 24 million by 2026, from US$ 16 million in 2020, at a CAGR of 6.8% during 2021-2026.

Global Oncolytic Virus Scope and Market Size
The global Oncolytic Virus market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncolytic Virus market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Oncolytic Virus market is segmented into
Imlygic
Oncorine
Others
Imlygic is the most widely used type which takes up about 85% of the total market share in 2019.

Segment by Application, the Oncolytic Virus market is segmented into
Melanoma
Other Cancers
The application of oncolytic virus therapy includes melanoma and other cancer, and the proportion of sales for melanoma in 2018 is about 85.52%.

The Oncolytic Virus market is analysed and market size information is provided by regions (countries). Segment by Application, the Oncolytic Virus market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Oncolytic Virus Market Share Analysis
Oncolytic Virus market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oncolytic Virus business, the date to enter into the Oncolytic Virus market, Oncolytic Virus product introduction, recent developments, etc.

The major vendors covered:
Amgen
Shanghai Sunway Biotech

レポート目次

1 Oncolytic Virus Market Overview
1.1 Oncolytic Virus Product Scope
1.2 Oncolytic Virus Segment by Type
1.2.1 Global Oncolytic Virus Sales by Type (2020-2026)
1.2.2 Imlygic
1.2.3 Oncorine
1.2.4 Others
1.3 Oncolytic Virus Segment by Application
1.3.1 Global Oncolytic Virus Sales Comparison by Application (2020-2026)
1.3.2 Melanoma
1.3.3 Other Cancers
1.4 Oncolytic Virus Market Estimates and Forecasts (2015-2026)
1.4.1 Global Oncolytic Virus Sales Growth Rate (2015-2026)
1.4.2 Global Oncolytic Virus Revenue and Growth Rate (2015-2026)
1.4.3 Global Oncolytic Virus Price Trends (2015-2026)

2 Oncolytic Virus Estimate and Forecast by Region
2.1 Global Oncolytic Virus Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Oncolytic Virus Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Oncolytic Virus Sales Market Share by Region (2015-2020)
2.2.2 Global Oncolytic Virus Revenue Market Share by Region (2015-2020)
2.3 Global Oncolytic Virus Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Oncolytic Virus Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Oncolytic Virus Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Oncolytic Virus Estimates and Projections (2015-2026)
2.4.2 Europe Oncolytic Virus Estimates and Projections (2015-2026)
2.4.3 China Oncolytic Virus Estimates and Projections (2015-2026)
2.4.4 Japan Oncolytic Virus Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Oncolytic Virus Estimates and Projections (2015-2026)
2.4.6 India Oncolytic Virus Estimates and Projections (2015-2026)
3 Global Oncolytic Virus Competition Landscape by Players
3.1 Global Top Oncolytic Virus Players by Sales (2015-2020)
3.2 Global Top Oncolytic Virus Players by Revenue (2015-2020)
3.3 Global Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncolytic Virus as of 2019)
3.4 Global Oncolytic Virus Average Price by Company (2015-2020)
3.5 Manufacturers Oncolytic Virus Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Oncolytic Virus Players (Opinion Leaders)
4 Global Oncolytic Virus Market Size by Type
4.1 Global Oncolytic Virus Historic Market Review by Type (2015-2020)
4.1.1 Global Oncolytic Virus Sales Market Share by Type (2015-2020)
4.1.2 Global Oncolytic Virus Revenue Market Share by Type (2015-2020)
4.1.3 Global Oncolytic Virus Price by Type (2015-2020)
4.2 Global Oncolytic Virus Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Oncolytic Virus Sales Forecast by Type (2021-2026)
4.2.2 Global Oncolytic Virus Revenue Forecast by Type (2021-2026)
4.2.3 Global Oncolytic Virus Price Forecast by Type (2021-2026)
5 Global Oncolytic Virus Market Size by Application
5.1 Global Oncolytic Virus Historic Market Review by Application (2015-2020)
5.1.1 Global Oncolytic Virus Sales Market Share by Application (2015-2020)
5.1.2 Global Oncolytic Virus Revenue Market Share by Application (2015-2020)
5.1.3 Global Oncolytic Virus Price by Application (2015-2020)
5.2 Global Oncolytic Virus Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Oncolytic Virus Sales Forecast by Application (2021-2026)
5.2.2 Global Oncolytic Virus Revenue Forecast by Application (2021-2026)
5.2.3 Global Oncolytic Virus Price Forecast by Application (2021-2026)

6 United States Oncolytic Virus Market Facts & Figures
6.1 United States Oncolytic Virus Sales Market Share by Company (2015-2020)
6.2 United States Oncolytic Virus Sales Market Share by Type (2015-2020)
6.3 United States Oncolytic Virus Sales Market Share by Application (2015-2020)

7 Europe Oncolytic Virus Market Facts & Figures
7.1 Europe Oncolytic Virus Sales Market Share by Company (2015-2020)
7.2 Europe Oncolytic Virus Sales Market Share by Type (2015-2020)
7.3 Europe Oncolytic Virus Sales Market Share by Application (2015-2020)

8 China Oncolytic Virus Market Facts & Figures
8.1 China Oncolytic Virus Sales Market Share by Company (2015-2020)
8.2 China Oncolytic Virus Sales Market Share by Type (2015-2020)
8.3 China Oncolytic Virus Sales Market Share by Application (2015-2020)

9 Japan Oncolytic Virus Market Facts & Figures
9.1 Japan Oncolytic Virus Sales Market Share by Company (3015-3030)
9.2 Japan Oncolytic Virus Sales Market Share by Type (2015-2020)
9.3 Japan Oncolytic Virus Sales Market Share by Application (2015-2020)

10 Southeast Asia Oncolytic Virus Market Facts & Figures
10.1 Southeast Asia Oncolytic Virus Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Oncolytic Virus Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Oncolytic Virus Sales Market Share by Application (2015-2020)

11 India Oncolytic Virus Market Facts & Figures
11.1 India Oncolytic Virus Sales Market Share by Company (2015-2020)
11.2 India Oncolytic Virus Sales Market Share by Type (2015-2020)
11.3 India Oncolytic Virus Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Oncolytic Virus Business
12.1 Amgen
12.1.1 Amgen Corporation Information
12.1.2 Amgen Business Overview
12.1.3 Amgen Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Amgen Oncolytic Virus Products Offered
12.1.5 Amgen Recent Development
12.2 Shanghai Sunway Biotech
12.2.1 Shanghai Sunway Biotech Corporation Information
12.2.2 Shanghai Sunway Biotech Business Overview
12.2.3 Shanghai Sunway Biotech Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Shanghai Sunway Biotech Oncolytic Virus Products Offered
12.2.5 Shanghai Sunway Biotech Recent Development

13 Oncolytic Virus Manufacturing Cost Analysis
13.1 Oncolytic Virus Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Oncolytic Virus
13.4 Oncolytic Virus Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Oncolytic Virus Distributors List
14.3 Oncolytic Virus Customers

15 Market Dynamics
15.1 Oncolytic Virus Market Trends
15.2 Oncolytic Virus Opportunities and Drivers
15.3 Oncolytic Virus Market Challenges
15.4 Oncolytic Virus Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Oncolytic Virus Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Oncolytic Virus Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Oncolytic Virus Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Oncolytic Virus Sales (K Units) by Region (2015-2020)
Table 5. Global Oncolytic Virus Sales Market Share by Region (2015-2020)
Table 6. Global Oncolytic Virus Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Oncolytic Virus Revenue Share by Region (2015-2020)
Table 8. Global Oncolytic Virus Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Oncolytic Virus Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Oncolytic Virus Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Oncolytic Virus Revenue Share Forecast by Region (2021-2026)
Table 12. Global Oncolytic Virus (K Units) of Key Companies (2015-2020)
Table 13. Global Oncolytic Virus Sales Share by Company (2015-2020)
Table 14. Global Oncolytic Virus Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Oncolytic Virus Revenue Share by Company (2015-2020)
Table 16. Global Oncolytic Virus by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncolytic Virus as of 2019)
Table 17. Global Oncolytic Virus Average Price (US$/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Oncolytic Virus Manufacturing Sites and Area Served
Table 19. Manufacturers Oncolytic Virus Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Oncolytic Virus Players
Table 22. Global Oncolytic Virus Sales (K Units) by Type (2015-2020)
Table 23. Global Oncolytic Virus Sales Share by Type (2015-2020)
Table 24. Global Oncolytic Virus Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Oncolytic Virus Price (K Units) by Type (2015-2020)
Table 26. Global Oncolytic Virus Sales Share by Type (2021-2026)
Table 27. Global Oncolytic Virus Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Oncolytic Virus Revenue Share by Type (2021-2026)
Table 29. Global Oncolytic Virus Price (K Units) by Type (2021-2026)
Table 30. Global Oncolytic Virus Sales (K Units) by Application (2015-2020)
Table 31. Global Oncolytic Virus Sales Share by Application (2015-2020)
Table 32. Global Oncolytic Virus Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Oncolytic Virus Price (K Units) by Application (2015-2020)
Table 34. Global Oncolytic Virus Sales (K Units) by Application (2021-2026)
Table 35. Global Oncolytic Virus Sales Share by Application (2021-2026)
Table 36. Global Oncolytic Virus Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Oncolytic Virus Revenue Share by Application (2021-2026)
Table 38. Global Oncolytic Virus Price (K Units) by Application (2021-2026)
Table 39. United States Oncolytic Virus Sales (K Units) by Company (2015-2020)
Table 40. United States Oncolytic Virus Sales Market Share by Company (2015-2020)
Table 41. United States Oncolytic Virus Sales (K Units) by Type (2015-2020)
Table 42. United States Oncolytic Virus Sales Market Share by Type (2015-2020)
Table 43. United States Oncolytic Virus Sales (K Units) by Application (2015-2020)
Table 44. United States Oncolytic Virus Sales Market Share by Application (2015-2020)
Table 45. Europe Oncolytic Virus Sales (K Units) by Company (2015-2020)
Table 46. Europe Oncolytic Virus Sales Market Share by Company (2015-2020)
Table 47. Europe Oncolytic Virus Sales (K Units) by Type (2015-2020)
Table 48. Europe Oncolytic Virus Sales Market Share by Type (2015-2020)
Table 49. Europe Oncolytic Virus Sales (K Units) by Application (2015-2020)
Table 50. Europe Oncolytic Virus Sales Market Share by Type (2015-2020)
Table 51. China Oncolytic Virus Sales (K Units) by Company (2015-2020)
Table 52. China Oncolytic Virus Sales Market Share by Company (2015-2020)
Table 53. China Oncolytic Virus Sales (K Units) by Type (2015-2020)
Table 54. China Oncolytic Virus Sales Market Share by Type (2015-2020)
Table 55. China Oncolytic Virus Sales (K Units) by Application (2015-2020)
Table 56. China Oncolytic Virus Sales Market Share by Application (2015-2020)
Table 57. Japan Oncolytic Virus Sales (K Units) by Company (2015-2020)
Table 58. Japan Oncolytic Virus Sales Market Share by Company (2015-2020)
Table 59. Japan Oncolytic Virus Sales (K Units) by Type (2015-2020)
Table 60. Japan Oncolytic Virus Sales Market Share by Type (2015-2020)
Table 61. Japan Oncolytic Virus Sales (K Units) by Application (2015-2020)
Table 62. Japan Oncolytic Virus Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Oncolytic Virus Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Oncolytic Virus Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Oncolytic Virus Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Oncolytic Virus Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Oncolytic Virus Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Oncolytic Virus Sales Market Share by Application (2015-2020)
Table 69. India Oncolytic Virus Sales (K Units) by Company (2015-2020)
Table 70. India Oncolytic Virus Sales Market Share by Company (2015-2020)
Table 71. India Oncolytic Virus Sales (K Units) by Type (2015-2020)
Table 72. India Oncolytic Virus Sales Market Share by Type (2015-2020)
Table 73. India Oncolytic Virus Sales (K Units) by Application (2015-2020)
Table 74. India Oncolytic Virus Sales Market Share by Application (2015-2020)
Table 75. Amgen Corporation Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 78. Amgen Oncolytic Virus Product
Table 79. Amgen Recent Development
Table 80. Shanghai Sunway Biotech Corporation Information
Table 81. Shanghai Sunway Biotech Description and Business Overview
Table 82. Shanghai Sunway Biotech Oncolytic Virus Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 83. Shanghai Sunway Biotech Oncolytic Virus Product
Table 84. Shanghai Sunway Biotech Recent Development
Table 85. Production Base and Market Concentration Rate of Raw Material
Table 86. Key Suppliers of Raw Materials
Table 87. Oncolytic Virus Distributors List
Table 88. Oncolytic Virus Customers List
Table 89. Oncolytic Virus Market Key Trends
Table 90. Oncolytic Virus Key Opportunities and Drivers
Table 91. Oncolytic Virus Market Challenges
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncolytic Virus Product Picture
Figure 2. Global Oncolytic Virus Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Oncolytic Virus Market Share by Application in 2020 & 2026
Figure 6. Melanoma Examples
Figure 7. Other Cancers Examples
Figure 8. Global Oncolytic Virus Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Oncolytic Virus Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Oncolytic Virus Price Trends Growth Rate (2015-2026) (US$/Unit)
Figure 11. Global Oncolytic Virus Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Oncolytic Virus Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Oncolytic Virus Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Oncolytic Virus Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Oncolytic Virus Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Oncolytic Virus Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Oncolytic Virus Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Oncolytic Virus Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Oncolytic Virus Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Oncolytic Virus Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Oncolytic Virus Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Oncolytic Virus Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Oncolytic Virus Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Oncolytic Virus Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Oncolytic Virus Players Market Share by Revenue in Oncolytic Virus 2015 & 2019
Figure 26. Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Oncolytic Virus Revenue Share by Type (2015-2020)
Figure 28. Global Oncolytic Virus Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Oncolytic Virus Revenue Share by Application (2015-2020)
Figure 30. Global Oncolytic Virus Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Oncolytic Virus Sales Market Share by Type in 2019
Figure 32. United States Oncolytic Virus Sales Market Share by Type in 2019
Figure 33. Europe Oncolytic Virus Sales Market Share by Company in 2019
Figure 34. Europe Oncolytic Virus Sales Market Share by Type in 2019
Figure 35. Europe Oncolytic Virus Sales Market Share by Application in 2019
Figure 36. China Oncolytic Virus Sales Market Share by Company in 2019
Figure 37. China Oncolytic Virus Sales Market Share by Type in 2019
Figure 38. China Oncolytic Virus Sales Market Share by Application in 2019
Figure 39. Japan Oncolytic Virus Sales Market Share by Company in 2019
Figure 40. Japan Oncolytic Virus Sales Market Share by Type in 2019
Figure 41. Japan Oncolytic Virus Sales Market Share by Application in 2019
Figure 42. Southeast Asia Oncolytic Virus Sales Market Share by Company in 2019
Figure 43. Southeast Asia Oncolytic Virus Sales Market Share by Type in 2019
Figure 44. Southeast Asia Oncolytic Virus Sales Market Share by Application in 2019
Figure 45. India Oncolytic Virus Sales Market Share by Company in 2019
Figure 46. India Oncolytic Virus Sales Market Share by Type in 2019
Figure 47. India Oncolytic Virus Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Oncolytic Virus
Figure 50. Manufacturing Process Analysis of Oncolytic Virus
Figure 51. Oncolytic Virus Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed